Medpace Holdings, Inc. (MEDP)
$600.65-$10.92 (-1.79%) Today
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 19 | 134,616 | $82.21M |
| Option exercise | 18 | 37,592 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
85 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Susan E. Burwig - Officer | Option exercise | Common Stock | 12,000 | $166.73 | $2.00M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| Jesse J. Geiger - Officer | Option exercise | Common Stock | 31,707 | $138.87 | $4.40M | |
| Jesse J. Geiger - Officer | Open-market sale | Common Stock | 31,707 | $455.30 | $14.44M | |
| Jesse J. Geiger - Officer | Option exercise | Employee Stock Option (Right to Buy) | 31,707 | $0.00 | - | |
| Stephen P. Ewald - Officer | Option exercise | Common Stock | 3,500 | $138.87 | $486K | |
| Stephen P. Ewald - Officer | Option exercise | Employee Stock Option (Right to Buy) | 3,500 | $0.00 | - | |
| Brian T. Carley - Director | Option exercise | Common Stock | 6,472 | $54.99 | $356K | |
| Brian T. Carley - Director | Option exercise | Stock Option (Right to Buy) | 6,472 | $0.00 | - | |
| Susan E. Burwig - Officer | Option exercise | Common Stock | 10,984 | $107.93 | $1.19M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 10,984 | $0.00 | - | |
| Susan E. Burwig - Officer | Option exercise | Common Stock | 10,000 | $107.93 | $1.08M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 668 | $590.69 | $395K | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 23,178 | $593.25 | $13.75M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 5,698 | $590.47 | $3.36M | |
| Brian T. Carley - Director | Grant or award | Restricted Stock Unit | 143 | $592.46 | $85K | |
| Cornelius P. McCarthy III - Director | Grant or award | Restricted Stock Unit | 113 | $592.46 | $67K | |
| Robert O. Kraft - Director | Grant or award | Restricted Stock Unit | 130 | $592.46 | $77K | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 41,331 | $606.88 | $25.08M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 15,151 | $593.46 | $8.99M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 59,025 | $607.78 | $35.87M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 42,392 | $615.52 | $26.09M | |
| Susan E. Burwig - Officer | Open-market sale | Common Stock | 20,000 | $609.15 | $12.18M | |
| Kevin M. Brady - Officer | Option exercise | Common Stock | 3,000 | $166.73 | $500K | |
| Kevin M. Brady - Officer | Open-market sale | Common Stock | 3,000 | $590.35 | $1.77M | |
| Kevin M. Brady - Officer | Gift | Common Stock | 170 | $0.00 | - | |
| Kevin M. Brady - Officer | Option exercise | Employee Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 6,830 | $598.49 | $4.09M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 21,858 | $592.18 | $12.94M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 23,862 | $592.07 | $14.13M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 7,191 | $590.84 | $4.25M | |
| Robert O. Kraft - Director | Option exercise | Common Stock | 6,472 | $54.99 | $356K | |
| Robert O. Kraft - Director | Open-market sale | Common Stock | 6,472 | $591.85 | $3.83M | |
| Robert O. Kraft - Director | Option exercise | Stock Option (Right to Buy) | 6,472 | $0.00 | - | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 14,747 | $595.26 | $8.78M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 6,047 | $591.00 | $3.57M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 5,312 | $603.23 | $3.20M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 5,128 | $601.37 | $3.08M | |
| Susan E. Burwig - Officer | Open-market sale | Common Stock | 18,000 | $605.00 | $10.89M | |
| Jesse J. Geiger - Officer | Open-market sale | Common Stock | 21,503 | $595.66 | $12.81M | |
| Fred B. Davenport Jr. - Director | Open-market sale | Common Stock | 5,972 | $581.88 | $3.47M | |
| Fred B. Davenport Jr. - Director | Option exercise | Stock Option (Right to Buy) | 6,472 | $0.00 | - | |
| Fred B. Davenport Jr. - Director | Option exercise | Common Stock | 6,472 | $54.99 | $356K | |
| Stephen P. Ewald - Officer | Option exercise | Common Stock | 18,230 | $166.73 | $3.04M | |
| Stephen P. Ewald - Officer | Open-market sale | Common Stock | 15,230 | $598.85 | $9.12M | |
| Stephen P. Ewald - Officer | Option exercise | Employee Stock Option (Right to Buy) | 18,230 | $0.00 | - | |
| Susan E. Burwig - Officer | Open-market sale | Common Stock | 2,000 | $605.01 | $1.21M | |
| Jesse J. Geiger - Officer | Option exercise | Common Stock | 19,460 | $166.73 | $3.24M | |
| Jesse J. Geiger - Officer | Option exercise | Common Stock | 3,568 | $166.73 | $595K | |
| Jesse J. Geiger - Officer | Open-market sale | Common Stock | 19,460 | $605.12 | $11.78M | |
| Jesse J. Geiger - Officer | Open-market sale | Common Stock | 3,568 | $585.00 | $2.09M | |
| Jesse J. Geiger - Officer | Option exercise | Employee Stock Option (Right to Buy) | 19,460 | $0.00 | - | |
| Jesse J. Geiger - Officer | Option exercise | Employee Stock Option (Right to Buy) | 3,568 | $0.00 | - | |
| Robert O. Kraft - Director | Option exercise | Common Stock | 57 | - | - | |
| Robert O. Kraft - Director | Option exercise | Restricted Stock Unit | 57 | $0.00 | - | |
| Cornelius P. McCarthy III - Director | Option exercise | Common Stock | 49 | - | - | |
| Cornelius P. McCarthy III - Director | Option exercise | Restricted Stock Unit | 49 | $0.00 | - | |
| Brian T. Carley - Director | Option exercise | Common Stock | 62 | - | - | |
| Brian T. Carley - Director | Option exercise | Restricted Stock Unit | 62 | $0.00 | - | |
| Susan E. Burwig - Officer | Option exercise | Common Stock | 10,000 | $107.93 | $1.08M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Kraft Robert O. | Director | 3,858 | $2.38M | View on EDGAR | |
| Brady Kevin M. | Officer | 3,400 | $2.13M | View on EDGAR | |
| Carley Brian T | Director | 5,000 | $3.04M | View on EDGAR |
Medpace Holdings, Inc. (MEDP) had 16 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for MEDP runs to 85 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of MEDP were filed in the last 90 days.
19 insider sales of MEDP were filed in the last 90 days, totaling $82.21M.
This page tracks MEDP Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MEDP to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
